Beacon Pharmaceuticals

Last updated

Beacon Pharmaceuticals PLC
Type Public
DSE:  BEACONPHAR, CSE:  BEACONPHAR
Industry Pharmaceutics
Biotechnology
Founded2006;17 years ago (2006)
Headquarters,
Bangladesh
Key people
Mohammad Ebadul Karim Bulbul, (MD)
Products Sofosvel, Darvoni, Tagrix, Crizonix, Daclavir, Soforal, Afanix, Axinix, Brigaix, Baricinix, Cabozanix, Dasanix, Hernix, Elbonix, Ibrutix, Lenvanix, Palbonix, Regonix, Tofacinix, and Wedica
RevenueDecrease2.svgUS$56 million (2019)
Increase2.svgUS$27 million (2019)
Increase2.svgUS$4 million (2019)
Total assets Increase2.svgUS$100 million (2021
Number of employees
4,000 (2021)
Website beaconpharma.com.bd

Beacon Pharmaceuticals PLC is a Bangladeshi pharmaceutical company that develops generic version of medications.

Beacon manufactures more than 200 generic drugs and 65 oncology products. Beacon is the first company in Bangladesh to start export of cancer drugs. [1] [2] The company is exporting its products to Asia, Africa, Europe and Latin America. Beacon is public limited company listed in Dhaka & Chittagong stock exchange. About 2000 people are working in this company. [3] [4] [5]

Beacon has introduced a number of global first generics. [6]

The company's commercially available products include velpatasvir/sofosbuvir, sofosbuvir/daclatasvir, osimertinib, crizotinib, daclatasvir, sofosbuvir, afatinib, axitinib, brigatinib, baricitinib, cabozantinib, dasatinib, neratinib, eltrombopag, ibrutinib, lenvatinib, palbociclib, regorafenib, tofacitinib, and trelagliptin.

BEACON Medicare Limited(BML) [7] is the exclusive global marketing & distribution partner of Beacon Pharmaceuticals Limited.

Related Research Articles

<span class="mw-page-title-main">Cipla</span> Indian multinational pharmaceutical company

Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai. Cipla primarily develops medicines to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and many other medical conditions.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

Bangladesh Export Import Company Limited, commonly known by its trade name BEXIMCO, is a Bangladeshi multinational conglomerate holding company, headquartered in Dhaka, Bangladesh. It was founded in the early 1970s.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

<span class="mw-page-title-main">Teva Pharmaceuticals</span> Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva Pharmaceuticals was the largest generic drug manufacturer, when it was surpassed briefly by US-based Pfizer. Teva regained its market leader position once Pfizer spun off its generic drug division in a merger with Mylan, forming the new company Viatris at the end of 2020. Overall, Teva is the 18th largest pharmaceutical company in the world.

<span class="mw-page-title-main">Square Pharmaceuticals</span> Bangladeshi pharmaceutical company

Square Pharmaceuticals Ltd. is a Bangladeshi multinational pharmaceutical company. It was founded in 1958 by Samson H. Chowdhury along with three of his friends PK Saha, Kazi Harunur Roshid and Radhabinod Rai as a private firm. It went public in 1991 and is listed on the Dhaka Stock Exchange and on the Chittagong Stock Exchange Square Pharmaceutical started to export different antibiotics and medicine across the world from 1987. Now it exports its medicine to 36 countries of the world.

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

<span class="mw-page-title-main">Beximco Pharma</span> Pharmaceutical company in Bangladesh

Beximco Pharmaceuticals Ltd also known as Beximco Pharma, is a pharmaceutical company in Bangladesh. It is a part of Bangladesh Export Import Company Limited (BEXIMCO).

Eskayef Pharmaceuticals Ltd., also known as SK+F, is a pharmaceutical company in Bangladesh. It belongs to the Transcom Group. Simeen Rahman is the Managing Director and CEO of the company.

<span class="mw-page-title-main">Incepta Pharmaceuticals</span> Bangladeshi pharmaceutical company

Incepta Pharmaceuticals Limited is a Bangladeshi pharmaceutical company based in Dhaka that manufactures and markets generic drugs and vaccines. Abdul Muktadir is the chairman of the company.

<span class="mw-page-title-main">Sun Pharma</span> Indian multinational pharmaceutical company

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin.

Renata Limited, also known as Renata, is one of the top ten pharmaceutical manufacturers in Bangladesh. Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products. The company also manufactures animal therapeutics and nutrition products. Renata currently employs about 2300 people in its head office in Mirpur, Dhaka and its three production facilities in Mirpur, Dhaka, Rajendrapur, Gazipur and Bhaluka, Mymensingh.

<span class="mw-page-title-main">Grindeks</span> Company based in Riga, Latvia

JSC Grindex is an internationally operating Latvian pharmaceutical company with headquarters in Riga, Latvia. Its portfolio consists of original products, generics, and active pharmaceutical ingredients. It mostly focuses on cardiovascular, central nervous system, anti-cancer, and diabetes medicines. Grindex is the leading pharmaceutical manufacturer in the Baltic States. In 2021 Grindex imported products to more than 90 countries.

<span class="mw-page-title-main">Aurobindo Pharma</span> Indian multinational pharmaceutical company

Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.

<span class="mw-page-title-main">Orion Group (Bangladesh)</span>

Orion Group is one of the largest Bangladeshi industrial conglomerates. The industries under this conglomerate include Orion Pharma Ltd, chemicals, pharmaceuticals, infrastructure development, agribusiness, hospitality, textiles, aviation etc. Orion was established by Obaidul Karim, the chairman of the group, and Salman Obaidul Karim, his the managing director. It built the Mayor Hanif flyover in Dhaka. The tallest building in Bangladesh, City Centre Dhaka is built by this group. The company is also the sole franchisee of Krispy Kreme and Fish & Co. restaurants in Bangladesh.

<span class="mw-page-title-main">Salman F Rahman</span> Member of Jatiya Sangsad

Salman Fazlur Rahman is a Bangladeshi businessman, adviser to the Prime Minister of Bangladesh, and a member of the Jatiya Sangsad. Currently, he is holding the rank of a cabinet minister and serving as the Private Industry and Investment Adviser to Bangladesh Prime Minister Sheikh Hasina. Earlier, he served as the private sector development affairs adviser to her. He was ranked 1685th on the list of billionaires in the world published by Beijing-based Hurun Gobal in 2017. He is the vice chairman of BEXIMCO Group, one of the largest conglomerates in Bangladesh. He was the president of several trade bodies including Association of Television Channel Owners (ATCO).

<span class="mw-page-title-main">Sofosbuvir/daclatasvir</span> Combination drug

Daclatasvir/sofosbuvir is a two-drug combination for the treatment of hepatitis C. It is given as a single daily pill containing daclatasvir, a viral NS5A inhibitor, and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase NS5B.

Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara. It is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. It is also termed to be a market leader in macrolides segment of anti-infective drugs in India.

<span class="mw-page-title-main">Natco Pharma</span>

Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations active pharmaceutical ingredients and crop health science products, and also provides contract manufacturing services. It is a major producer of branded oncology medicines and hepatitis C drugs. The company specialises in producing complex medicines at affordable prices. In 2019, Natco launched its crop health sciences division.

Square Group is a Bangladeshi diversified conglomerate based in Dhaka. Samuel S Chowdhury is the chairman and Tapan Chowdhury is managing director of Square Group. Square Group has 60 thousand employees.

References

  1. Chowdhury, Raihan M. (13 August 2012). "Bangladesh begins export of anti-cancer drugs". The Financial Express. Dhaka. Archived from the original on 25 August 2016. Retrieved 11 August 2016.
  2. "Anti-cancer drugs now made in Bangladesh". The Daily Star. 23 February 2010.
  3. Ahmed, Gazi Towhid (28 January 2015). "Beacon Pharma to invest Tk 290cr for expansion". The Daily Star.
  4. http://www.secbd.org/ProspectusOfBeaconPharma.pdf Archived 2017-12-17 at the Wayback Machine , Securities and Exchange Commission (Bangladesh)
  5. "Beacon Pharmaceuticals Limited". Dhaka Stock Exchange .
  6. Rajagopal, Divya (27 July 2016). "US' Gilead faces competition from Bangladesh's Beacon pharma". The Economic Times. Mumbai.
  7. "Home". beaconmedicare.com.bd.